LetterCorrespondence
Interleukin 22, a Potential Therapeutic Target for Rheumatoid Arthritis
QIANG XIE, SHI-CUN WANG and JUN LI
The Journal of Rheumatology November 2012, 39 (11) 2220-2221; DOI: https://doi.org/10.3899/jrheum.120757
QIANG XIE
School of Pharmacy, Anhui Medical University, PET/CT Center, Anhui Provincial Hospital;
MDSHI-CUN WANG
MM
JUN LI
MD
REFERENCES
- 1.↵
- Da Rocha LF Jr.,
- Duarte AL,
- Dantas AT,
- Mariz HA,
- Pitta ID,
- Galdino SL,
- et al.
- 2.↵
- 3.↵
- 4.↵
- Leipe J,
- Schramm MA,
- Grunke M,
- Baeuerle M,
- Dechant C,
- Nigg AP,
- et al.
- 5.↵
- 6.↵
- 7.↵
- Ren J,
- Feng Z,
- Lv Z,
- Chen X,
- Li J
- 8.↵
- 9.↵
- Marijnissen RJ,
- Koenders MI,
- Smeets RL,
- Stappers MH,
- Nickerson-Nutter C,
- Joostern LA,
- et al.
- 10.↵
- 11.↵
- 12.↵
In this issue
The Journal of Rheumatology
Vol. 39, Issue 11
1 Nov 2012
Interleukin 22, a Potential Therapeutic Target for Rheumatoid Arthritis
QIANG XIE, SHI-CUN WANG, JUN LI
The Journal of Rheumatology Nov 2012, 39 (11) 2220-2221; DOI: 10.3899/jrheum.120757